Radiometer recently launched its CE-marked TCM5 transcutaneous monitor, addressing the critical care needs of neonatal, pediatric and adult patients, as well as sleep clinic and home care environments. With a sleek appearance, intuitive colour touchscreen interface and clear visual display, this all-new device has been designed with the end user in mind, offering continuous, non-invasive monitoring of tcpO2 and tcpCO2, as well as Masimo SET SpO2, perfusion index and pulse rate in real time. The unique gold-plated sensors automatically recalibrate when placed in the calibration chamber, enabling highly reliable measurements even with prolonged use, and on-board interactive tutorials minimize training requirements. Initially available in Australia, Austria, Belgium, France, Germany, Japan, Luxembourg, New Zealand, South Africa, Switzerland, the Netherlands, the United Arab Emirates and the United Kingdom, the TCM5 monitor offers a choice of two distinct versions tailored to different customer and patient needs. The TCM5 BASIC monitor is ideal for diagnostic investigations in sleep clinics and respiratory care in the home environment. Lightweight and compact with a clear numeric display, it enables accurate determination of ventilation and oxygenation status overnight and the dedicated sleep mode offers silent operation and a dark screen, ensuring that patients are not disturbed. The premium TCM5 FLEX monitor is designed for critical care departments. It is particularly beneficial in neonatal intensive care due to its non-invasive nature. Numeric and trend displays, together with audible and visual alarms, instantly alert clinicians to any change in a patient’s status, enabling immediate intervention. For round-the-clock monitoring of neonates, a special NICU mode automatically monitors the duration of contact with the skin and controls the sensor temperature, helping to prevent damage to sensitive skin.
Read more

The BLENDER TM is a medical device used to provide a mix of O2 and medical AIR to the patient (FiO2). It is intended to adjust the concentration of Oxygen (from 21 to 100 %) in medical AIR. It is provided with two outlets to connect a 15 or 30 l/min flowmeter and a 1.5,5 or 15 l/min flowmeter. It is connected to source of pressurized gas on the wall or to pressure regulators’quick-release connectors using two hosepipes medical AIR and O2. BLENDER TM is mainly intended for paediatric and neonatalogy low flow applications.
Read more

PENTAX Europe and Hitachi Medical Systems Europe, are launching a new ultrasound video bronchoscope for endobronchial ultrasound (EBUS) – the EB19-J10U. This features crystal clear ultrasound and endoscopic imaging to provide advanced diagnostic accuracy, contributing to a smooth facilitation of EBUS-TBNA and maximizing patient safety. It is ergonomically designed for ease of operation and high working comfort. The combination of a broad portfolio of Hitachi Ultrasound systems and their progressive technical features and PENTAX Medical video processors with superb visualization capabilities offers an innovative solution. The PENTAX Medical ultrasound endoscopes are explicitly designed for use with Hitachi’s sophisticated ultrasound systems. The EB19-J10U is the latest product developed as a result of this partnership. State-of-the-art technology from both companies, ensures the highest imaging performance with crystal clear image quality for precise visualization of the airway wall, surrounding lymph nodes and adjacent structures. In combination with PENTAX Medical video processors, the HD fully digital video and 100% Color-CCD-Chip in the tip technology, delivers high definition endoscopic image quality, providing a real-time full screen endoscopic image with visibility of the ultrasound probe for improved visualization and navigation. Hitachi’s multi-layered Crystal Technology incorporated into the ultrasound transducer of the EB19-J10U, allows more efficient transmission and reception of the ultrasound pulse with minimal energy loss. It enables very high resolution and clear images, resulting in improved sensitivity, tissue differentiation from near field to deep areas, and optimal needle visualization supporting effective tissue sampling. An enlarged working channel of 2.2 mm enables the use of a wide range of standard-sized EBUS-TBNA needles for tissue acquisition. The intended use of the new EB19-J10U was expanded to endobronchial and esophageal endosonography which allows the user to perform a combined EBUS-TBNA and EUS-(B)-FNA procedure with only one ultrasound endoscope. This follows the recommendations of the European Guidelines: “Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer” from the European Society of Gastrointestinal Endoscopy (ESGE) Guideline1, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS). The new EB19-J10U offers a much larger field of vision, combined with high quality ultrasound, allowing better visualization of the airways. Its wide operational channel and new ergonomics with improved grip has benefitted both the ease of use and the manoeuvrability. All these product advancements are contributing to an accurate, real-time ultrasound-guided trans-bronchial needle aspiration (EBUS-TBNA). The endoscope, with its single use suction valve, single use cleaning brushes and newly developed cleaning adapters meets the highest market standards for reprocessing and product hygiene. 
Read more

The next generation CE-marked Proxima bedside blood gas analyser (BGA) incorporates a new design and an extended analyte panel. Parameters now added to the new system include glucose and calculated parameters, such as P/F ratio and temperature corrected gases. The ability to monitor blood gases and measure blood glucose frequently and easily, directly by the patient, can enable earlier interventions and closer patient management, which is vital in fast changing critical situations. As a patient-dedicated system, Proxima is always connected to the patient via their arterial line and ready to go instantly. Since results are also delivered without the caregiver leaving the patient’s bedside, this significantly reduces time to result compared to conventional benchtop analysers. Its novel design means the system can travel with the patient on their pathway through the hospital. This is possible since the Proxima sensor contains an array of proven biosensor technology on a silicon chip, each a miniaturized version of the electrochemical sensors used in a traditional blood gas analyser. In addition to the sensor, the next generation Proxima system includes a medical grade tablet monitor with an intuitive touchscreen user interface. All results are reported to the monitor and seamlessly transferred directly into laboratory information systems and electronic patient records. This is a key requirement for the successful implementation of point-of-care (POC) testing.
As an ex-vivo analyser operating as a closed system, blood is drawn directly from the patient and over the Proxima sensor. Following analysis, all blood is returned to the patient, meaning that there is no blood loss and risk of iatrogenic anemia is reduced. Furthermore, infection risk to staff and patients is minimized as the arterial line remains closed throughout sampling. The design of Proxima also reduces pre-analytical errors due to the delivery of a high integrity blood sample direct to the sensor for immediate analysis with no mixing or anti-coagulant required. The addition of glucose to the new Proxima’s analyte panel is significant as glucose measurements play a key part in the care of critically ill patients. Both hyperglycemia and hypoglycemia are associated with increased morbidity and mortality in intensive care unit (ICU) patients. Keeping patients in normal glycemic range is difficult with current systems. The ability to regularly monitor arterial blood glucose using Proxima will support closer clinical management for improved glycemic control.
Read more

Mega Electronics has launched an updated version of their ‘all-in-one’ ECG sensor lineup, the Faros ECG sensors. The update includes heavily reduced power consumption and a totally new Li-ion battery, with up to 7 days of ECG recording time without recharging and up to 30 days of ECG recording capacity. The Finland-based company has designed the sensors in a way which supports multiple applications: apart from being capable of recording Holter ECG, the sensors can also be used as cardiac event monitors or mobile cardiac telemetry devices with specific mobile phone apps. The newest feature is a completely new cardiac rehab solution, which is a real-time, wireless ECG group monitoring system for 1-16 patients with easy-to-read reporting.

Read more